Crohn's disease Trials in Campinas, Brazil
Conditions / Crohn's disease / Campinas, Brazil
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06226883 | A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease | RECRUITING | — |
| NCT06430801 | A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) | RECRUITING | — |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | RECRUITING | — |
| NCT03466411 | A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT04232553 | A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03926130 | A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease | COMPLETED | PHASE3 |
| NCT06937099 | Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight | RECRUITING | — |
| NCT00306215 | A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease | COMPLETED | PHASE2 |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease | RECRUITING | PHASE3 |
| NCT05923073 | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | PHASE3 |